Cribstone Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Cribstone Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4	Closed	–	–	549
2019 Q3	$0	Hold	4	–	–	﹤0.01%	625
2019 Q2	$0	Hold	4	–	–	﹤0.01%	690
2019 Q1	$0	Hold	4	–	–	﹤0.01%	715
2018 Q4	$0	Hold	4	–	–	﹤0.01%	769
2018 Q3	$0	Hold	4	–	–	﹤0.01%	799
2018 Q2	$0	Hold	4	–	–	﹤0.01%	814
2018 Q1	$0	Hold	4	–	–	﹤0.01%	862
2017 Q4	$0	Hold	4	–	–	﹤0.01%	897
2017 Q3	$0	Hold	4	–	–	﹤0.01%	747
2017 Q2	$0	Hold	4	–	–	﹤0.01%	748
2017 Q1	$0	Hold	4	–	–	﹤0.01%	763
2016 Q4	$0	Hold	4	–	–	﹤0.01%	722
2016 Q3	$0	Hold	4	–	–	﹤0.01%	732
2016 Q2	$0	Buy	+4	New	+$28	﹤0.01%	731

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cribstone Capital Management's SPPI Position: Q4 2019 in Review

Cribstone Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2019, closing a stake of 4 shares.

Cribstone Capital Management first reported a position in SPPI in Q2 2016 and held it in 14 quarters. The position peaked at $0 in Q3 2019. 169 funds tracked by Wall St. Rank hold SPPI as of Q4 2019.

Cribstone Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2019 after selling out during the quarter.
Cribstone Capital Management sold 4 Spectrum Pharmaceuticals Inc shares in Q4 2019.
Cribstone Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2016 and held it in 14 quarters.
Cribstone Capital Management's Spectrum Pharmaceuticals Inc position peaked at $0 in Q3 2019.
169 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2019.

Based on Cribstone Capital Management's 13F filing for Q4 2019, filed 8 Jan 2020.